FIGURE

Figure 6

ID

ZDB-FIG-201130-78

Publication

Lu et al., 2020 - Generation and Application of the Zebrafish heg1 Mutant as a Cardiovascular Disease Model

Other Figures

All Figure Page

Back to All Figure Page

Figure 6

Monomers pharmacological validation of heg1^∆25 zebrafish mutants. (A) Phenotype observation and the relative movement of RBCs in PVC analysis of heg1^∆25 embryos treated with four monomers. (B) The optimal concentrations of the four monomers, salvianolic acid B, paeoniflorin, ferulic acid and aspirin. N = 40 embryos for each concentration. (C) Comparison of heart rate of zebrafish embryos in each group. (D) Comparison of SV-BA distance of zebrafish embryos in each group. (E) Comparison of pericardial area of zebrafish embryos in each group. Data are represented as mean ± SE from three independent experiments, * p < 0.05, ** p < 0.01, and *** p < 0.001 (Student’s t-test).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomolecules